Are psychiatric diagnoses of psychosis scientific and useful? The case of schizophrenia

Journal of Mental Health

Volumn 19, Issue 4, 2010, Pages 305-317

  Van Os, Jim ^a,b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Diagnosis; psychotic disorders; schizophrenia

Indexed keywords

ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIAGNOSTIC APPROACH ROUTE; DISEASE CLASSIFICATION; INFORMATION RETRIEVAL; INTERNATIONAL CLASSIFICATION OF DISEASES; MENTAL DEVELOPMENT; MENTAL FUNCTION; MENTAL HEALTH SERVICE; PSYCHOSIS; SCHIZOPHRENIA; SOCIAL ATTITUDE; VALIDITY;

ATTITUDE OF HEALTH PERSONNEL; CAREGIVERS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEEDBACK; HUMANS; MENTAL DISORDERS; PREJUDICE; PUBLIC OPINION; RISK ASSESSMENT; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SELF CONCEPT; SOCIAL DISTANCE; STEREOTYPING; UNITED STATES;

EID: 77954787521     PISSN: 09638237     EISSN: 13600567     Source Type: Journal    
DOI: 10.3109/09638237.2010.492417     Document Type: Article

References (68)

1. Allardyce, J., McCreadie, R.G., Morrison, G., & van Os, J. (2007). Do symptom dimensions or categorical diagnoses best discriminate between known risk factors for psychosis? Social Psychiatry and Psychiatric Epidemiology, 42(6), 429-437.
2. Allardyce, J., Morrison, G., Van Os, J., Kelly, J., Murray, R.M., & McCreadie, R.G. (2000). Schizophrenia is not disappearing in south-west Scotland. British Journal of Psychiatry, 177, 38-41.
3. Angst, J. (2007). The bipolar spectrum. British Journal of Psychiatry, 190, 189-191.
4. Artaloytia, J.F., Arango, C., Lahti, A., Sanz, J., Pascual, A., Cubero, P., et al. (2006). Negative signs and symptoms secondary to antipsychotics: A double-blind, randomized trial of a single dose of placebo, haloperidol, and risperidone in healthy volunteers. American Journal of Psychiatry, 163(3), 488-493.
5. Arts, B., Jabben, N., Krabbendam, L., & van Os, J. (2008). Meta-analyses of cognitive functioning in euthymic bipolar patients and their first-degree relatives. Psychological Medicine, 38(6), 771-785.
6. Bentall, R. (2004). Madness explained. Psychosis and human nature. London: Penguin Books.
7. Berridge, K.C., & Robinson, T.E. (2003). Parsing reward. Trends in Neurosciences, 26(9), 507-513.
8. Brockington, I. (1992a). Schizophrenia: Yesterday's concept. European Psychiatry, 7, 203-207.
9. Brockington, I.F., Roper, A., Copas, J., Buckley, M., Andrade, C.E., Wigg, P., et al. (1991). Schizophrenia, bipolar disorder and depression. A discriminant analysis, using 'lifetime' psychopathology ratings. British Journal of Psychiatry, 159, 485-494.
10. Cannon, M., Caspi, A., Moffitt, T.E., Harrington, H., Taylor, A., Murray, R.M., et al. (2002). Evidence for earlychildhood, pan-developmental impairment specific to schizophreniform disorder: Results from a longitudinal birth cohort. Archives of General Psychiatry, 59(5), 449-456.
11. Cardno, A.G., Rijsdijk, F.V., Sham, P.C., Murray, R.M., & McGuffin, P. (2002a). A twin study of genetic relationships between psychotic symptoms. American Journal of Psychiatry, 159(4), 539-545.
12. Cardno, A.G., Sham, P.C., Farmer, A.E., Murray, R.M., & McGuffin, P. (2002b). Heritability of Schneider's firstrank symptoms. British Journal of Psychiatry, 180, 35-38.
13. Carpenter, W.T., Jr., Arango, C., Buchanan, R.W., & Kirkpatrick, B. (1999). Deficit psychopathology and a paradigm shift in schizophrenia research. Biological Psychiatry, 46(3), 352-360.
14. Carpenter, W.T., Jr., Heinrichs, D.W., & Wagman, A.M. (1988). Deficit and nondeficit forms of schizophrenia: The concept. American Journal of Psychiatry, 145(5), 578-583.
15. Cougnard, A., Marcelis,M., Myin-Germeys, I., De Graaf, R., Vollebergh,W., Krabbendam, L., et al. (2007). Does normal developmental expression of psychosis combine with environmental risk to cause persistence of psychosis? A psychosis proneness-persistence model. Psychological Medicine, 37(4), 513-527.
16. Craddock, N., & Owen, M.J. (2007). Rethinking psychosis: The disadvantages of a dichotomous classification now outweigh the advantages. World Psychiatry, 6(2), 84-91.
17. Cuesta, M.J., Peralta, V., & Zarzuela, A. (2007). Empirical validation of competing definitions of schizophrenia: A poly-diagnostic study of cognitive impairment in non-affective psychosis. Schizophrenia Research, 95(1-3), 39-47.
18. Dikeos, D.G., Wickham, H., McDonald, C., Walshe, M., Sigmundsson, T., Bramon, E., et al. (2006). Distribution of symptom dimensions across Kraepelinian divisions. British Journal of Psychiatry, 189, 346-353.
19. Dominguez, M., Viechtbauer, W., Simons, C.J., van Os, J., & Krabbendam, L. (2009a). Are psychotic psychopathology and neurocognition orthogonal? A systematic review of their associations. Psychological Bulletin, 135(1), 157-171.
20. Dominguez, M., Wichers, M., Lieb, R., Wittchen, H.-U., & van Os, J. (2009b). Evidence that onset of clinical psychosis is the outcome of progressively more persistent subclinical psychotic experiences: An 8-year cohort study. Schizophrenia Bulletin, PUBMED publication: doi:10.1093/schbul/ sbp022.
21. Eaton, W.W., Thara, R., Federman, B., Melton, B., & Liang, K.Y. (1995). Structure and course of positive and negative symptoms in schizophrenia. Archives of General Psychiatry, 52(2), 127-134.
22. Fine, C., Gardner, M., Craigie, J., & Gold, I. (2007). Hopping, skipping or jumping to conclusions? Clarifying the role of the JTC bias in delusions. Cognitive Neuropsychiatry, 12(1), 46-77.
23. Flaum, M., & Andreasen, N. (1995). The reliability of distinguishing primary versus secondary negative symptoms. Comprehensive Psychiatry, 36(6), 421-427.
24. Gold, J.M. (2008). Is cognitive impairment in schizophrenia ready for diagnostic prime time? World Psychiatry, 7(1), 32-33.
25. Hanssen, M., Bak, M., Bijl, R., Vollebergh, W., & van Os, J. (2005). The incidence and outcome of subclinical psychotic experiences in the general population. British Journal of Clinical Psychology, 44(Part 2), 181-191. (Pubitemid 40873432)
26. Hanssen, M.S., Bijl, R.V., Vollebergh, W., & van Os, J. (2003). Self-reported psychotic experiences in the general population: A valid screening tool for DSM-III-R psychotic disorders? Acta Psychiatrica Scandinavica, 107(5), 369-377.
27. Jablensky, A. (2006). Subtyping schizophrenia: Implications for genetic research. Molecular Psychiatry, 11(9), 815-836.
28. Jensen, J., Willeit, M., Zipursky, R.B., Savina, I., Smith, A.J., Menon, M., et al. (2007). The formation of abnormal associations in schizophrenia: Neural and behavioral evidence. Neuropsychopharmacology, 33, 473-479.
29. Kapur, S. (2003). Psychosis as a state of aberrant salience: A framework linking biology, phenomenology, and pharmacology in schizophrenia. American Journal of Psychiatry, 160(1), 13-23.
30. Kapur, S. (2004). How antipsychotics become anti-'psychotic' - from dopamine to salience to psychosis. Trends in Pharmacological Sciences, 25(8), 402-406.
31. Keller, M.B., Klein, D.N., Hirschfeld, R.M., Kocsis, J.H., McCullough, J.P.,Miller, I., et al. (1995). Results of the DSM-IV mood disorders field trial. American Journal of Psychiatry, 152(6), 843-849.
32. Kendell, R., & Jablensky, A. (2003). Distinguishing between the validity and utility of psychiatric diagnoses. American Journal of Psychiatry, 160(1), 4-12.
33. Kendler, K.S., McGuire, M., Gruenberg, A.M., Spellman, M., O'Hare, A., & Walsh, D. (1993). The Roscommon Family Study. II. The risk of nonschizophrenic nonaffective psychoses in relatives. Archives of General Psychiatry, 50(8), 645-652. (Pubitemid 23229273)
34. Kitamura, T., Okazaki, Y., Fujinawa, A., Yoshino, M., & Kasahara, Y. (1995). Symptoms of psychoses. A factoranalytic study. British Journal of Psychiatry, 166(2), 236-240.
35. Krabbendam, L., Arts, B., van Os, J., & Aleman, A. (2005). Cognitive functioning in patients with schizophrenia and bipolar disorder: A quantitative review. Schizophrenia Research, 80(2-3), 137-149.
36. Lataster, T., Myin-Germeys, I., Derom, C., Thiery, E., & van Os, J. (2009). Evidence that self-reported psychotic experiences represent the transitory developmental expression of genetic liability to psychosis in the general population. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 150B, 1078-1084.
37. Leff, J. (2004). Book review: Madness explained. Psychosis and human nature. British Journal of Psychiatry, 184, 374-375.
38. Lichtenstein, P., Yip, B.H., Bjork, C., Pawitan, Y., Cannon, T.D., Sullivan, P.F., et al. (2009). Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: A population-based study. Lancet, 373(9659), 234-239.
39. Linscott, R.J., Allardyce, J., & van Os, J. (2009). Seeking verisimilitude in a class: A systematic review of evidence that the criterial clinical symptoms of schizophrenia are taxonic. Schizophrenia Bulletin, Epub ahead of print. DOI: sbn181 [pii] 10.1093/schbul/sbn181.
40. Maj, M., Pirozzi, R., Formicola, A.M., Bartoli, L., & Bucci, P. (2000). Reliability and validity of the DSM-IV diagnostic category of schizoaffective disorder: preliminary data. Journal of Affective Disorders, 57(1-3), 95-98.
41. Maric, N., Myin-Germeys, I., Delespaul, P., De Graaf, R., Vollebergh, W., & Van Os, J. (2004). Is our concept of schizophrenia influenced by Berkson's bias? Social Psychiatry and Psychiatric Epidemiology, 39(8), 600-605.
42. McGorry, P.D., Bell, R.C., Dudgeon, P.L., & Jackson, H.J. (1998). The dimensional structure of first episode psychosis: An exploratory factor analysis. Psychological Medicine, 28(4), 935-947.
43. Mortensen, P.B., Pedersen, C.B., Melbye, M., Mors, O., & Ewald, H. (2003). Individual and familial risk factors for bipolar affective disorders in Denmark. Archives of General Psychiatry, 60(12), 1209-1215.
44. Murray, G.K., Corlett, P.R., Clark, L., Pessiglione,M., Blackwell, A.D., Honey, G., et al. (2008). Substantia nigra/ ventral tegmental reward prediction error disruption in psychosis. Molecular Psychiatry, 13(3), 239, 267-276.
45. Murray, R.M., Sham, P., Van Os, J., Zanelli, J., Cannon, M., & McDonald, C. (2004). A developmental model for similarities and dissimilarities between schizophrenia and bipolar disorder. Schizophrenia Research, 71(2-3), 405-416.
46. Perala, J., Suvisaari, J., Saarni, S.I., Kuoppasalmi, K., Isometsa, E., Pirkola, S., et al. (2007). Lifetime prevalence of psychotic and bipolar I disorders in a general population. Archives of General Psychiatry, 64(1), 19-28.
47. Peralta, V., & Cuesta, M.J. (1999). Diagnostic significance of Schneider's first-rank symptoms in schizophrenia. Comparative study between schizophrenic and non-schizophrenic psychotic disorders. British Journal of Psychiatry, 174, 243-248.
48. Peters, E.R., Joseph, S.A., & Garety, P.A. (1999). Measurement of delusional ideation in the normal population: Introducing the PDI (Peters et al. Delusions Inventory). Schizophrenia Bulletin, 25(3), 553-576.
49. Poulton, R., Caspi, A., Moffitt, T.E., Cannon, M., Murray, R., & Harrington, H. (2000). Children's self-reported psychotic symptoms and adult schizophreniform disorder: A 15-year longitudinal study [In Process Citation]. Archives of General Psychiatry, 57(11), 1053-1058.
50. Regeer, E., Krabbendam, L., De Graaf, R., Ten Have, M., Nolen, W.A., & Van Os, J. (in press). Berkson's bias and the mood dimensions of bipolar disorder. International Journal of Methods in Psychiatric Research, 18, 279-286.
51. Remington, G., Chong, S.A., & Kapur, S. (1999). Distinguishing change in primary and secondary negative symptoms. American Journal of Psychiatry, 156(6), 974-975.
52. Robins, E., & Guze, S.B. (1970). Establishment of diagnostic validity in psychiatric illness: Its applications to schizophrenia. American Journal of Psychiatry, 126, 983-987.
53. Roiser, J.P., Stephan, K.E., den Ouden, H.E., Barnes, T.R., Friston, K.J., & Joyce, E.M. (2009). Do patients with schizophrenia exhibit aberrant salience? Psychological Medicine, 39(2), 199-209.
54. Sackett, D.L., Richardson, W.S., Rosenberg, W., & Haynes, R.B. (1997). Evidence-based medicine. New York: Churchill Livingstone.
55. Sato, M. (2006). Renaming schizophrenia: A Japanese perspective. World Psychiatry, 5(1), 53-55.
56. Schultz, W. (2007). Multiple dopamine functions at different time courses. Annual Review of Neuroscience, 30, 259-288.
57. Tarrier, N. (2006). Negative symptoms in schizophrenia: Comments from a clinical psychology perspective. Schizophrenia Bulletin, 32(2), 231-233.
58. Van Os, J. (2000). Commentary on "A default analysis for schizophrenia research." Schizophrenia Bulletin, 26(1), 163-165.
59. Van Os, J. (2009a). A salience dysregulation syndrome. British Journal of Psychiatry, 194, 101-103.
60. Van Os, J. (2009b). 'Salience syndrome' replaces 'schizophrenia' in DSM-V and ICD-11: Psychiatry's evidencebased entry into the 21st century? Acta Psychiatrica Scandinavica, 120, 363-372.
61. Van Os, J., Fahy, T.A., Jones, P., Harvey, I., Sham, P., Lewis, S., et al. (1996). Psychopathological syndromes in the functional psychoses: Associations with course and outcome. Psychological Medicine, 26(1), 161-176. (Pubitemid 26031812)
62. Van Os, J., Gilvarry, C., Bale, R., van-Horn, E., Tattan, T., White, I., et al. (1999a). To what extent does symptomatic improvement result in better outcome in psychotic illness? Psychological Medicine, 29(5), 1183-1195.
63. Van Os, J., Gilvarry, C., Bale, R., Van Horn, E., Tattan, T., White, I., et al. (1999b). A comparison of the utility of dimensional and categorical representations of psychosis. UK700 Group. Psychological Medicine, 29(3), 595-606.
64. Van Os, J., Gilvarry, C., Bale, R., van-Horn, E., Tattan, T., White, I., et al. (2000a). Diagnostic value of the DSM and ICD categories of psychosis: An evidence-based approach. Social Psychiatry and Psychiatric Epidemiology, 35(7), 305-311.
65. Van Os, J., Hanssen, M., Bijl, R., & Ravelli, A. (2000b). Straus (1969) revisited: A psychosis continuum in the general population? Schizophrenia Research, 45(1-2), 11-20.
66. Van Os, J., Linscott, R.J., Myin-Germeys, I., Delespaul, P., & Krabbendam, L. (2009). A systematic review and meta-analysis of the psychosis continuum: Evidence for a psychosis proneness-persistence-impairment model of psychotic disorder. Psychological Medicine, 39(2), 179-195.
67. Van Os, J., & Verdoux, H. (2003). Diagnosis and classification of schizophrenia: Categories versus dimensions, distributions versus disease. In R.M. Murray, P.B. Jones, E. Susser, J. Van Os, M. Cannon (Eds.), The epidemiology of schizophrenia (ISBN 052177540x) (pp. 364-411). Cambridge: Cambridge University Press.
68. van Praag, H.M. (1976). About the impossible concept of schizophrenia. Comprehensive Psychiatry, 17(4), 481-497.